Additionally, it was discovered that chronic myeloid leukemia (CML) cells overexpressed GAPDH, contributing to CML resistance to chemotherapy [19]. The gene discussed is GAPDH; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.